Haisco Pharmaceutical Group Co., Ltd.

SZSE:002653 Stock Report

Market Cap: CN¥38.4b

Haisco Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 002653?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,000,0000.902%
Institutions101,646,3079.16%
General Public169,232,18915.3%
Individual Insiders828,381,09474.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 83.64% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
36%
Jun Min Wang
399,550,400CN¥13.8b0%no data
19.6%
Xiu Lian Fan
217,315,600CN¥7.5b0%no data
13.9%
Wei Zheng
154,128,300CN¥5.3b0%no data
5.02%
Ping Shen
55,705,894CN¥1.9b0%no data
1.42%
China Universal Asset Management Company Ltd.
15,736,345CN¥544.5m0%0.24%
0.9%
Jinan Jiangshan Investment Partnership Enterprise (Limited Partnership)
10,000,000CN¥346.0m0%no data
0.79%
Zhong Ou Fund Management Co., Ltd
8,731,817CN¥302.1m0%0.16%
0.78%
Fullgoal Fund Management Co. Ltd.
8,632,120CN¥298.7m0%0.11%
0.7%
China Life Asset Management Company Limited
7,710,590CN¥266.8m0%0.28%
0.67%
National Council for Social Security Fund
7,417,200CN¥256.6m0%0.04%
0.61%
Bank of China Investment Management Co., Ltd.
6,718,846CN¥232.5m0%0.71%
0.48%
E Fund Management Co., Ltd.
5,278,612CN¥182.6m0%0.03%
0.31%
CIB Fund Management Co., Ltd
3,401,100CN¥117.7m0%0.97%
0.29%
Yinhua Fund Management Co., Ltd.
3,271,770CN¥113.2m0%0.1%
0.28%
China Asset Management Co. Ltd.
3,146,896CN¥108.9m0%0.02%
0.27%
Hwabao WP Fund Management Co., Ltd
2,986,787CN¥103.3m0%0.09%
0.26%
Baoying Fund Management Co. Ltd.
2,868,300CN¥99.2m0%0.54%
0.24%
China Fund Management Co., Ltd.
2,655,596CN¥91.9m0%1.2%
0.23%
China Southern Asset Management Co., Ltd.
2,505,075CN¥86.7m0%0.03%
0.19%
GF Fund Management Co., Ltd.
2,129,834CN¥73.7m0%0.02%
0.16%
Truvalue Asset Management Co.,Ltd.
1,735,300CN¥60.0m0%0.3%
0.15%
The Vanguard Group, Inc.
1,688,105CN¥58.4m-0.01%no data
0.14%
First State Cinda Fund Management Company Limited
1,554,500CN¥53.8m0%0.12%
0.14%
CCB Principal Asset Management Co., Ltd.
1,548,900CN¥53.6m0%0.11%
0.12%
Shanghai Orient Securities Asset Management Co., Ltd.
1,353,600CN¥46.8m0%0.05%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 05:04
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Haisco Pharmaceutical Group Co., Ltd. is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yue GaoChangjiang Securities Co. LTD.
Shanshan LiChina Merchants Securities Co. Ltd.
Sophia ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)